Bottom Line: A new study assesses chemotherapy-induced peripheral neuropathy in 121 long-term survivors of childhood cancer to detail clinical, functional, neurophysiological and patient-reported outcomes of the condition.
Why The Research Is Interesting: Childhood and adolescent cancer survival rates have improved and it’s important to understand the long-term effect of cancer treatment. Chemotherapy-induced peripheral neuropathy is a potentially long-lasting adverse effect of chemotherapy agents that can be toxic to peripheral nerves.
Authors: Susanna B. Park, Ph.D., of the University of Sydney, Australia, and coauthors
To read the full study, please visit the For The Media website.
Editor’s Note: The article contains funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
To place an electronic embedded link in your story: Links will be live at the embargo time: http://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2018.0963
Susanna B. Park